Seeking Alpha
 

The Clorox Company (CLX)

- NYSE
  • Fri, May 1, 9:23 AM
    • Clorox (NYSE:CLX) reports sales rose 5% if the impact of currency swings is backed out.
    • Volume was up 1% for the quarter.
    • Gross margin rate +110 bps to 43.2%.
    • Segment revenue: Cleaning: $442M (+1%), Household: $451M (+5%), Lifestyle: $243M (+3%), International: $265M (flat & 10% growth on currency-neutral basis).
    • FY2015 Guidance: Sales: ~+1% to +2%; EBIT margin: ~flat; Diluted EPS: $4.45 to $4.55; Tax rate: ~34%.
    • FQ3 results
    | 1 Comment
  • Wed, Feb. 4, 8:54 AM
    • Clorox (NYSE:CLX) reports sales grew in FQ2 by 6% if the impact of currency swings is backed out.
    • Volume was up 4% for the period.
    • Gross margin rate +10 bps to 42.5%.
    • Segment revenue growth: Cleaning: $447M (+3%), Household: $371M (+5%), Lifestyle: $246M (+4%), International: $281M (-2% & 11% growth on currency-neutral basis).
    • FY2015 Guidance: Sales: ~1% growth; EBIT margin: ~flat; Diluted EPS: $4.40 to $4.55; Tax rate: ~34%.
    • CLX +4.0% premarket.
    | Comment!
  • Oct. 31, 2014, 9:04 AM
    • Clorox (NYSE:CLX) reports sales grew in Q3 by close to 3% if the impact of currency swings is backed out.
    • Volume was up 1% for the period.
    • Gross margin rate -70 bps to 42.8%.
    • Segment revenue growth: Cleaning +2%, Household +5%, Lifestyle -1%, International flat.
    • CLX +2.2% premarket.
    | Comment!
  • Sep. 22, 2014, 9:51 AM
    • Clorox (CLX +6.8%) announces it will end doing business in Venezuela through its local affiliate.
    • The company also backed its previous sales and EPS guidance.
    • Shares of Clorox have cruised to an all-time off the news, with a weekend report of takeover interest also contributing to the rally.
    | Comment!
  • Sep. 22, 2014, 9:08 AM
    | Comment!
  • Sep. 22, 2014, 8:10 AM
    • Shares of Clorox (NYSE:CLX) are higher in early trading after the New York Post reports the company was the target of takeover interest during the last three to six months.
    • A number of analysts think an acquisition premium will linger over the stock due to the stable of strong brands Clorox possesses.
    • CLX +2.7% premarket to $93.01.
    | Comment!
  • Dec. 6, 2013, 10:03 AM
    • Consumer staples stocks are getting some run out of a positive read on consumer sentiment and an improvement in the unemployment rate in the U.S. The group is outpacing broader market averages in early action.
    • Advancers: Clorox (CLX) +2.2%, Procter & Gamble (PG) +2.0%, Energizer (ENR) +1.9%, Unilever (UL) +1.3%, Colgate-Palmolive (CL) +1.3%, Kimberly Clark (KMB) +1.1%, Avon Products (AVP) +1.0%.
    • Related ETFs: XLP, VDC, FXG, RHS, PSL, PSCC, FSTA
    | Comment!
  • Sep. 20, 2013, 9:47 AM
    • Shares of Clorox (CLX -1.2%) slip after Credit Suisse take a dimmer view of the company's prospects.
    • Analysts with the firm think Clorox will be hard-pressed to meet the targets it set for 2014.
    | Comment!
  • May 1, 2013, 9:05 AM
    Shares of Clorox (CLX) stumble, down 1.1% premarket, after the company misses estimates and issues guidance for 2013 below consensus. Looking further down the road, Clorox sees sales growing at a 2% to 4% clip in 2014 with new product innovations contributing.
    | Comment!
  • Apr. 24, 2013, 10:48 AM
    The rough patch hit by Procter & Gamble in emerging markets isn't giving unnoticed by some of its peers with Kimberly-Clark (KMB -1.2%), Colgate-Palmolive (CL -1.7%), and Clorox (CLX -1.5%) all showing weakness. ETF watch: Is the frothy run of consumer staple ETFs (XLP, FXG, VDC) at risk of running out of steam as sector rotation picks up?
    | 2 Comments
  • Feb. 4, 2013, 11:30 AM
    Shares of Clorox (CLX +1.8%) cruise to new all-time highs after the company put in a strong FQ2 and raises its outlook for FY13. A national outbreak of a flu epidemic helped drive up sales of the Clorox's cleaning products and disinfectant wipes during the most recent period.
    | Comment!
  • Jun. 1, 2012, 9:24 AM
    Clorox (CLX) CEO Don Knauss says the company will be aggressive in adding properties to its healthcare portfolio over the next five years. He notes that a particular focus could be companies offering disinfection products. CLX +0.4% premarket in defiance of a broad market selloff.
    | Comment!
  • May 2, 2012, 10:47 AM
    Clorox (CLX -4.1%) falls after missing with its FQ3 report and projecting that 2013 EPS will fall in a range of $4.20-$4.35 - short of the forecast of analysts. A source of pressure for the company has been gross margins - which fell to 42.3% from the 44.1% mark of a year ago.
    | Comment!
  • May 2, 2012, 8:55 AM
    Clorox (CLX): FQ3 EPS of $1.02 misses by $0.02. Revenue of $1.4B (+7.4% Y/Y) beats by $50M. Shares -2.3% premarket. (PR)
    | Comment!
  • Feb. 3, 2012, 8:36 AM
    Clorox (CLX): FQ2 EPS of $0.82 beats by $0.13. Revenue of $1.22B (+4% Y/Y) beats by $20M. Shares +1.6% premarket. (PR)
    | Comment!
  • Sep. 26, 2011, 9:00 AM
    Premarket gainers: MELA +109%. OMEX +13%. CTIC +7%. DB +7%. ING +7%. BCS +6%. DANG +6%. LYG +5%. AEG +4%. NFLX +4%. PT +4%. AMD +4%. NOK +4%. CS +4%. CCL +3%. YRCW +3%. ALU +3%. MT +3%. TOT +3%. AKS +3%. IHG +3%. X +3%.
    Losers: EK -17%. CLX -6%. SPIL -3%. SLW -3%.
    | Comment!
Visit Seeking Alpha's
CLX vs. ETF Alternatives
Company Description
Clorox Co is engaged in manufacturing and marketing consumer & professional products. It operates through four segments including; Cleaning, Household, Lifestyle and International.